A Promising Antiviral Is Being Tested for the Coronavirus—but Results Are Not Yet Out
The drug remdesivir is effective against many other viruses, and some experts are optimistic that it—or similar compounds—may work for the pathogen responsible for COVID-19
FDA Identifies First Drug Shortage Blamed on Coronavirus—but Won’t Name the Drug
The agency says patients can use alternatives while it works with manufacturers to mitigate the situation
Despite a “Double-Barreled” Flu Season, the Vaccine Is Mostly Doing Its Job
This year’s flu shot is working relatively well to prevent influenza, particularly among children
Researchers Map Structure of Coronavirus “Spike” Protein
The finding could help lay the groundwork for a vaccine
Responses to “The Cancer Industry: Hype vs. Reality”
Readers critique a journalist’s critique of cancer medicine
The Women’s Health Pioneer You’ve Probably Never Heard Of
The 19th-century black “doctress” Rebecca Davis Lee Crumpler should be on everyone’s radar
Sanofi Announces It Will Work with HHS to Develop Coronavirus Vaccine
The vaccine likely won’t be ready to test in people for at least a year
To Fight Coronavirus Outbreak, Doctors Deploy Drugs Targeting HIV, Malaria and Ebola
Despite flimsy evidence, trying these drugs in humans is the only way to know if they will work against COVID-19
Cancer Therapy in 2020
The promise of host-response profiling
The Cancer Industry: Hype vs. Reality
Cancer medicine generates enormous revenues but marginal benefits for patients
The Cardio-Oncologist Will See You Now
A growing medical subspecialty focuses on the nexus between cancer and heart disease
Penicillium Fungus Hosts Surprising Opioid Compounds
Next-generation opioids may spring from a tiny fungus protein